The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Validation of the Princess Margaret immune oncology prognostic index (PM-IPI) for patients (pts) treated in immune oncology (IO) early phase trials.
 
Daphne Day
No Relationships to Disclose
 
Anna Spreafico
No Relationships to Disclose
 
Stephanie Lheureux
Consulting or Advisory Role - AstraZeneca; AstraZeneca
 
Albiruni Ryan Abdul Razak
No Relationships to Disclose
 
Aaron Richard Hansen
No Relationships to Disclose
 
Lisa Wang
No Relationships to Disclose
 
Marcus O. Butler
Honoraria - Bristol-Myers Squibb; Merck; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Immunovaccine; Merck; Novartis
Expert Testimony - Merck
 
Lillian L. Siu
Leadership - Agios (I)
Consulting or Advisory Role - AstraZeneca/MedImmune; Boehringer Ingelheim; Celgene; Merck; Pfizer
Research Funding - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; MedImmune; Merck; Novartis; Pfizer
 
Philippe L. Bedard
Consulting or Advisory Role - Genentech/Roche (Inst); Pfizer (Inst); Sanofi (Inst)
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Oncothyreon (Inst); PTC Therapeutics (Inst); Sanofi (Inst); SERVIER (Inst); SignalChem (Inst)